Literature DB >> 18565595

Immune response to fungal infections.

Jose L Blanco1, Marta E Garcia.   

Abstract

The immune mechanisms of defence against fungal infections are numerous, and range from protective mechanisms that were present early in evolution (innate immunity) to sophisticated adaptive mechanisms that are induced specifically during infection and disease (adaptive immunity). The first-line innate mechanism is the presence of physical barriers in the form of skin and mucous membranes, which is complemented by cell membranes, cellular receptors and humoral factors. There has been a debate about the relative contribution of humoral and cellular immunity to host defence against fungal infections. For a long time it was considered that cell-mediated immunity (CMI) was important, but humoral immunity had little or no role. However, it is accepted now that CMI is the main mechanism of defence, but that certain types of antibody response are protective. In general, Th1-type CMI is required for clearance of a fungal infection, while Th2 immunity usually results in susceptibility to infection. Aspergillosis, which is a disease caused by the fungus Aspergillus, has been the subject of many studies, including details of the immune response. Attempts to relate aspergillosis to some form of immunosuppression in animals, as is the case with humans, have not been successful to date. The defence against Aspergillus is based on recognition of the pathogen, a rapidly deployed and highly effective innate effector phase, and a delayed but robust adaptive effector phase. Candida albicans, part of the normal microbial flora associated with mucous surfaces, can be present as congenital candidiasis or as acquired defects of cell-mediated immunity. Resistance to this yeast is associated with Th1 CMI, whereas Th2 immunity is associated with susceptibility to systemic infection. Dermatophytes produce skin alterations in humans and other animals, and the essential role of the CMI response is to destroy the fungi and produce an immunoprotective status against re-infection. The resolution of the disease is associated with a delayed hypersensitive response. There are many effective veterinary vaccines against dermatophytoses. Malassezia pachydermatis is an opportunistic yeast that needs predisposing factors to cause disease, often related to an atopic status in the animal. Two species can be differentiated within the genus Cryptococcus with immunologic consequences: C. neoformans infects predominantly immunocompromised hosts, and C. gattii infects non-immunocompromised hosts. Pneumocystis is a fungus that infects only immunosupressed individuals, inducing a host defence mechanism similar to that induced by other fungal pathogens, such as Aspergillus.

Entities:  

Mesh:

Year:  2008        PMID: 18565595     DOI: 10.1016/j.vetimm.2008.04.020

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  53 in total

1.  Robust Th1 and Th17 immunity supports pulmonary clearance but cannot prevent systemic dissemination of highly virulent Cryptococcus neoformans H99.

Authors:  Yanmei Zhang; Fuyuan Wang; Kristin C Tompkins; Andrew McNamara; Aditya V Jain; Bethany B Moore; Galen B Toews; Gary B Huffnagle; Michal A Olszewski
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

Review 2.  Regulating the T-cell immune response toward the H99 strain of Cryptococcus neoformans.

Authors:  Kathleen T Montone
Journal:  Am J Pathol       Date:  2009-10-29       Impact factor: 4.307

Review 3.  Small intestinal fungal overgrowth.

Authors:  Askin Erdogan; Satish S C Rao
Journal:  Curr Gastroenterol Rep       Date:  2015-04

4.  Exserohilum infections associated with contaminated steroid injections: a clinicopathologic review of 40 cases.

Authors:  Jana M Ritter; Atis Muehlenbachs; Dianna M Blau; Christopher D Paddock; Wun-Ju Shieh; Clifton P Drew; Brigid C Batten; Jeanine H Bartlett; Maureen G Metcalfe; Cau D Pham; Shawn R Lockhart; Mitesh Patel; Lindy Liu; Tara L Jones; Patricia W Greer; Jeltley L Montague; Elizabeth White; Dominique C Rollin; Cynthia Seales; Donna Stewart; Mark V Deming; Mary E Brandt; Sherif R Zaki
Journal:  Am J Pathol       Date:  2013-06-26       Impact factor: 4.307

Review 5.  Host immune defense against Aspergillus fumigatus: insight from experimental systemic (disseminated) infection.

Authors:  I Mirkov; S Stosic-Grujicic; M Kataranovski
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

6.  In vitro amphotericin B susceptibility of Malassezia pachydermatis determined by the CLSI broth microdilution method and Etest using lipid-enriched media.

Authors:  Sergio Álvarez-Pérez; José L Blanco; Teresa Peláez; Maite Cutuli; Marta E García
Journal:  Antimicrob Agents Chemother       Date:  2014-04-21       Impact factor: 5.191

7.  Antibodies generated against Streptococci protect in a mouse model of disseminated aspergillosis.

Authors:  Rebekah E Wharton; Emily K Stefanov; R Glenn King; John F Kearney
Journal:  J Immunol       Date:  2015-03-27       Impact factor: 5.422

Review 8.  Asthma and Fungus: Role in Allergic Bronchopulmonary Aspergillosis (ABPA) and Other Conditions.

Authors:  Meenu Singh; Nandini Paul; Shreya Singh; Gyan Ranjan Nayak
Journal:  Indian J Pediatr       Date:  2018-03-17       Impact factor: 1.967

9.  Dexamethasone-induced flares of Trichophyton rubrum masquerading as docetaxel cutaneous toxicity: a case report.

Authors:  Arun Azad; Melissa Kaufman; Jyotsna Jayarajan
Journal:  Cases J       Date:  2009-07-23

10.  Genome-wide transcriptional response of Silurana (Xenopus) tropicalis to infection with the deadly chytrid fungus.

Authors:  Erica Bree Rosenblum; Thomas J Poorten; Matthew Settles; Gordon K Murdoch; Jacques Robert; Nicole Maddox; Michael B Eisen
Journal:  PLoS One       Date:  2009-08-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.